Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Comparative analysis of hospitalization risk for incident heart failure in non-Hispanic Black versus non-Hispanic White individuals with type 2 diabetes on empagliflozin (Empa-AA): Insights from real-world data.
Journal: Diabetes, obesity & metabolism
Published: November 19, 2023
A meta-analysis of randomized controlled trials evaluating sodium-glucose co-transporter 2 inhibitors and incidental atrial fibrillation-Is there a true benefit?
Journal: Diabetes/metabolism research and reviews
Published: August 31, 2023
Diabetes-Related Microvascular Complications - A Practical Approach.
Journal: Primary care
Published: May 20, 2022
Cardiovascular benefits of GLP-1RA and SGLT-2i in women with type 2 diabetes.
Journal: Primary care diabetes
Published: September 21, 2021
The benefit of GLP-1RA in different age groups in the cardiovascular outcome trials.
Journal: Diabetes research and clinical practice
Published: February 01, 2021
GLP-1 RA and atrial fibrillation in the cardiovascular outcome trials.
Journal: Diabetes/metabolism research and reviews
Published: January 13, 2021
Sodium-glucose co-transporter-2 inhibitors and atrial fibrillation in the cardiovascular and renal outcome trials.
Journal: Diabetes, obesity & metabolism
Published: September 15, 2020
Transitioning to non-insulin therapy in a patient receiving high dose insulin.
Journal: Journal of the American Association of Nurse Practitioners
Published: April 14, 2020
Do GLP-1RAs and SGLT-2is reduce cardiovascular events in women with type 2 diabetes? A systematic review and meta-analysis.
Journal: Diabetes & metabolism
Published: March 10, 2020
Should Baseline Hemoglobin A1c or Dose of SGLT-2i Guide Treatment With SGLT-2i Versus DPP-4i in People With Type 2 Diabetes? A Meta-Analysis and Systematic Review.
Journal: Journal of clinical pharmacology
Published: November 19, 2019
Insulin therapy in patients with type 2 diabetes and high insulin resistance is associated with increased risk of complications and mortality.
Journal: Postgraduate medicine
Published: July 18, 2019
Do GLP-1RAs and SGLT-2is reduce cardiovascular events in black patients with type 2 diabetes? A systematic review and meta-analysis.
Journal: Diabetes, obesity & metabolism
Published: February 18, 2019
Last Updated: 09/26/2026